The ATTRACT trial may seem more attractive than it first looks for the management of acute deep vein thrombosis!

Kahn SR Shbaklo H Lamping DL et al . Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6: 1105–1112.

Guanella R Ducruet T Johri M et al . Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost 2011; 9: 2397–2405.

Schulman S Lindmarker P Holmstrom M et al . Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6-weeks or 6-months. J Thromb Haemost 2006; 4: 734–742.

Comerota AJ Grewal N Martinez JT et al . Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis. J Vasc Surg 2012; 55: 768–773.

Vedantham S Goldhaber SZ Julian JA et al . Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377: 2240–2252.

Kahn SR. Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. J Thromb Haemost 2009; 7: 884–888.

Enden T Haig Y Kløw NE et al . Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379: 31–38.

Haig Y Enden T Grøtta O et al . Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol 2016; 3: e64–e71.

Watson L Broderick C Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2016; 11: CD002783.

Sharifi M Bay C Mehdipour M et al . Thrombus obliteration by rapid percutaneous endovenous intervention in deep venous occlusion (TORPEDO) trial: midterm results. J Endovasc Ther 2012; 19: 273–280.

Chatterjee S Sharma A. Catheter-directed thrombolysis for acute deep vein thrombosis. Lancet 2012; 379: 1786.

Ganatra S Sharma A Levy M. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2018; 378: 1752–1753.

Lu Y Chen L Chen J et al . Catheter-directed thrombolysis versus standard anticoagulation for acute lower extremity deep vein thrombosis: a meta-analysis of clinical trials. Clin Appl Thromb Hemost 2017: 1076029617739703.

Kahn SR Comerota AJ Cushman M et al . The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 2014; 130: 1636–1661.

Meissner MH Gloviczki P Comerota AJ et al . Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012; 55: 1449–1462.

Wittens C Davies AH Bækgaard N et al . Management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2015; 49: 678–737.

Mahnken AH Thomson K de Haan M et al . CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Intervent Radiol 2014; 37: 889–897.

Seager MJ, Busuttil A, Dharmarajah B, et al. Choice– A Systematic Review of Endovenous Stenting in Chronic Venous Disease Secondary to Iliac Vein Obstruction. Eur J Vasc Endovasc Surg 2016; 51(1): 100–120.

Kearon C Akl EA Ornelas J et al . Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149: 315–352.